A safety and efficacy study of autologous bone marrow cell transplantation for HIV positive patients with cirrhosis
- Conditions
- HIV infection, AIDS, Cirrhosis
- Registration Number
- JPRN-UMIN000005174
- Lead Sponsor
- ational Center for Global Health and Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Not provided
Cases applicable to ANY condition of the following: 1) Hepatocellular carcinoma (HCC), except for cases having been treated completely without history of recurrence 2) Malignant tumor other than HCC 3) Alcoholic liver disease (ALD) 4) Hemoglobin under 8g/dL or Platelets under 20/ml at the registration 5) Esophageal or gastric varices with a risk of bursting, except for cases only with cured history of such conditions 6) Cases that cannot obtain the informed consent to autologous blood transfusion 7) Pregnancy 8) Renal dysfunction with 2mg/dL or higher serum creatinine 9) Performance Status 3 or 4 (assessment excludes hemophilic arthritis related daily life limitations) 10) not fit for general anesthesia 11) other conditions that doctor considered not suitable for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method